1. |
Moran EM. Epidemiological and clinical aspects of nonsteroidal antiinflammatory drugs and cancer risks [J]. J Environ Pathol Toxicol Oncol, 2002; 21(2)∶193.
|
2. |
Kloppel G. Pancreatic non-endocrine tumors. In: Kloppel G. Heitz (eds). Pancreatic pathology [M]. Edinburg, Scotand: Churchill Livingstone, 1984∶79.
|
3. |
Hermreck AS, Thomas CY 4th, Friesen SR. Inportance of pathologic staging in the surgical managment of adenocarcinoma of the exocrine pancreas [J]. Am J Surg, 1974; 127(6)∶653.
|
4. |
Molina MA, SitjaArnau M, Lemoine MG, et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal antiinflammatory drugs [J]. Cancer Res, 1999; 59(17)∶4356.
|
5. |
Ikeda N, Nakajima Y, Sho M, et al. The association of K-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma [J]. Cancer, 2001; 92(3)∶488.
|
6. |
Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer [J].Cancer Res, 2002; 62(3)∶632.
|
7. |
Costa C, Soares R, ReisFilho JS, et al. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer [J].J Clin Pathol, 2002; 55(6)∶429.
|
8. |
李繼坤, 鄭淼, 李遠芳, 等. p53及VEGF表達與結、直腸癌血道轉移發生的關系 [J]. 中國普外基礎與臨床雜志, 2002; 9(2)∶112.
|
9. |
Niedergethmann M, Hildenbrand R, Wostbrock B, et al. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas [J]. Pancreas, 2002; 25(2)∶122.
|
10. |
Seno H, Oshima M, Ishikawa TO, et al. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta 716) mouse intestinal polyps [J]. Cancer Res, 2002; 62(2)∶506.
|